| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A global study for acute myeloid leukemia with RARG rearrangement
|
Zhu, Hong-Hu
|
|
|
7 |
13 |
p. 2972-2982
|
artikel
|
| 2 |
American Society of Hematology, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panamena de Hematología, Sociedad Peruana de Hematología, and SVH 2023 guidelines for diagnosis of venous thromboembolism and for its management in special populations in Latin America
|
Neumann, Ignacio
|
|
|
7 |
13 |
p. 3005-3021
|
artikel
|
| 3 |
A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma
|
Sawalha, Yazeed
|
|
|
7 |
13 |
p. 2983-2993
|
artikel
|
| 4 |
A single F153Sβ3 mutation causes constitutive integrin αIIbβ3 activation in a variant form of Glanzmann thrombasthenia
|
Koukouritaki, Sevasti B.
|
|
|
7 |
13 |
p. 3180-3191
|
artikel
|
| 5 |
Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma
|
Forlenza, Christopher J.
|
|
|
7 |
13 |
p. 3225-3231
|
artikel
|
| 6 |
Burnout in US hematologists and oncologists: impact of compensation models and advanced practice provider support
|
Lee, Alfred Ian
|
|
|
7 |
13 |
p. 3058-3068
|
artikel
|
| 7 |
Challenges in applying diagnostic criteria for systemic mastocytosis
|
Boggs, Nathan A.
|
|
|
7 |
13 |
p. 3150-3154
|
artikel
|
| 8 |
C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia
|
de Boer, Esther C. W.
|
|
|
7 |
13 |
p. 3128-3139
|
artikel
|
| 9 |
Classification and genetics of pediatric B-other acute lymphoblastic leukemia by targeted RNA sequencing
|
Migita, Natacha Azussa
|
|
|
7 |
13 |
p. 2957-2971
|
artikel
|
| 10 |
Consensus recommendations on peripheral blood smear review: defining curricular standards and fellow competency
|
Chase, Matthew L.
|
|
|
7 |
13 |
p. 3244-3252
|
artikel
|
| 11 |
Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL
|
Griffin, Rosalie
|
|
|
7 |
13 |
p. 3169-3179
|
artikel
|
| 12 |
Editorial Board
|
|
|
|
7 |
13 |
p. i
|
artikel
|
| 13 |
FOXP1 regulates oxidative stress, SIRT1 expression, and resistance to chemotherapies in acute myeloid leukemia cells
|
Levavasseur, Francoise
|
|
|
7 |
13 |
p. 3265-3275
|
artikel
|
| 14 |
Front Matter
|
|
|
|
7 |
13 |
p. ii
|
artikel
|
| 15 |
Gata1s mutant mice display persistent defects in the erythroid lineage
|
Ling, Te
|
|
|
7 |
13 |
p. 3253-3264
|
artikel
|
| 16 |
Huynh A, Arnold DM, Michael JV, et al. Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S. Blood Adv. 2023;7(2):246-250.
|
|
|
|
7 |
13 |
p. 3113
|
artikel
|
| 17 |
Ilich A, Gernsheimer TB, Triulzi DJ, et al. Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia. Blood Adv. 2023;7(6):900-908.
|
|
|
|
7 |
13 |
p. 3022
|
artikel
|
| 18 |
Impact of allele-level HLA matching on outcomes after double cord blood transplantation in adults with malignancies
|
Fatobene, Giancarlo
|
|
|
7 |
13 |
p. 3297-3306
|
artikel
|
| 19 |
Interplay between hereditary and acquired factors determines the neutrophil counts in older individuals
|
Gagnon, Marie-France
|
|
|
7 |
13 |
p. 3232-3243
|
artikel
|
| 20 |
Invasive fungal infections after CLAG-M/CLAG chemotherapy for acute myeloid leukemia and high-grade myeloid neoplasms
|
Lindsay, Julian
|
|
|
7 |
13 |
p. 3140-3145
|
artikel
|
| 21 |
It’s high time to turn the spotlight on HbSC disease
|
Oluwole, Olubusola
|
|
|
7 |
13 |
p. 3320-3322
|
artikel
|
| 22 |
Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia
|
Heidenreich, Falk
|
|
|
7 |
13 |
p. 2994-3004
|
artikel
|
| 23 |
Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal
|
Geyer, Mark B.
|
|
|
7 |
13 |
p. 3087-3098
|
artikel
|
| 24 |
Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries
|
Jiao, Boshen
|
|
|
7 |
13 |
p. 3276-3283
|
artikel
|
| 25 |
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy
|
Wudhikarn, Kitsada
|
|
|
7 |
13 |
p. 3192-3198
|
artikel
|
| 26 |
Melanocortin/MC5R axis regulates the proliferation of hematopoietic stem cells in mice after ionizing radiation injury
|
Chen, Naicheng
|
|
|
7 |
13 |
p. 3199-3212
|
artikel
|
| 27 |
Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS
|
Guney, Ekin
|
|
|
7 |
13 |
p. 3307-3311
|
artikel
|
| 28 |
Most adults with severe HbSC disease are not treated with hydroxyurea
|
Ghunney, William Kwesi
|
|
|
7 |
13 |
p. 3312-3319
|
artikel
|
| 29 |
Natural history and rate of progression of retinopathy in adult patients with sickle cell disease: an 11-year follow-up study
|
Brandsen, Rajani P.
|
|
|
7 |
13 |
p. 3080-3086
|
artikel
|
| 30 |
Nawas MT, Sanchez-Escamilla M, Devlin SM, et al. Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation. Blood Adv. 2022;6(22):5898-5907.
|
|
|
|
7 |
13 |
p. 3323-3325
|
artikel
|
| 31 |
Older patients with chronic myeloid leukemia face suboptimal molecular testing and tyrosine kinase inhibitor adherence
|
Shallis, Rory M.
|
|
|
7 |
13 |
p. 3213-3224
|
artikel
|
| 32 |
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML
|
de Botton, Stéphane
|
|
|
7 |
13 |
p. 3117-3127
|
artikel
|
| 33 |
Personalized risk model for predicting risk of acute coronary syndrome in patients with myelodysplastic syndromes
|
Montarello, Natalie
|
|
|
7 |
13 |
p. 3032-3035
|
artikel
|
| 34 |
Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B
|
Shapiro, Amy D.
|
|
|
7 |
13 |
p. 3049-3057
|
artikel
|
| 35 |
Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS
|
Gladstone, Douglas E
|
|
|
7 |
13 |
p. 3075-3079
|
artikel
|
| 36 |
Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis
|
Mazahreh, Farah
|
|
|
7 |
13 |
p. 3069-3074
|
artikel
|
| 37 |
SECTM1-based CAR T cells enriched with CD7-low/negative subsets exhibit efficacy in CD7-positive malignancies
|
Wei, Wenwen
|
|
|
7 |
13 |
p. 2941-2951
|
artikel
|
| 38 |
Selective modulation of activated protein C activities by a nonactive site–targeting nanobody library
|
Sim, Derek S.
|
|
|
7 |
13 |
p. 3036-3048
|
artikel
|
| 39 |
Specific subtype distribution with impact on prognosis of TP53 single-hit and double-hit events in AML and MDS
|
Stengel, Anna
|
|
|
7 |
13 |
p. 2952-2956
|
artikel
|
| 40 |
TAK-981, a SUMOylation inhibitor, suppresses AML growth immune-independently
|
Kim, Han Sun
|
|
|
7 |
13 |
p. 3155-3168
|
artikel
|
| 41 |
The gut microbiota in patients with polycythemia vera is distinct from that of healthy controls and varies by treatment
|
Eickhardt-Dalbøge, Christina Schjellerup
|
|
|
7 |
13 |
p. 3326-3337
|
artikel
|
| 42 |
The use of FDA-approved medications for preventing vaso-occlusive events in sickle cell disease
|
Cronin, Robert M.
|
|
|
7 |
13 |
p. 3114-3116
|
artikel
|
| 43 |
Undetectable measurable residual disease is associated with improved outcomes in AML irrespective of treatment intensity
|
Bazinet, Alexandre
|
|
|
7 |
13 |
p. 3284-3296
|
artikel
|
| 44 |
USP1 promotes the aerobic glycolysis and progression of T-cell acute lymphoblastic leukemia via PLK1/LDHA axis
|
Liu, Shuguang
|
|
|
7 |
13 |
p. 3099-3112
|
artikel
|
| 45 |
Value of embedded palliative care: outpatient palliative care and health care utilization for patients with hematologic malignancies
|
Tsang, Mazie
|
|
|
7 |
13 |
p. 3146-3149
|
artikel
|
| 46 |
Zinc for infection prevention in children with sickle cell anemia: a randomized double-blind placebo-controlled trial
|
Namazzi, Ruth
|
|
|
7 |
13 |
p. 3023-3031
|
artikel
|
Tijdschrift beschrijving